TRVI
Trevi Therapeutics, Inc. · Healthcare
New Enterprise Associates 16, L.P. bought $5.0M of Trevi Therapeutics, Inc.
10% owner
Bought$4,999,998
$1.90Price
2,631,578Shares
+34%Stake
What TRVI did for a copier
- $1,000 copied at Thu, Apr 14 open, $2.92
- $818
- S&P 500, same days
- −6.4%
Measured over 30 trading days, to the May 27 close.
New Enterprise Associates 16, L.P.'s record
4 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Apr 11. Filed Wed, Apr 13, 5:00 PM ET, after the close. Returns use the Apr 14 open and the May 27 close. Not investment advice.